CARPEM is an Integrated Cancer Research Site (SIte de Recherche Intégrée sur le Cancer – SIRIC) focused on the development of new personalized cancer treatments while working on prevention.
SIRIC were established by the National Cancer Institute (INCa). The SIRIC label of our the CARPEM program is an acknowledgement of the excellence of cancer research of our research and clinic teams that have significant expertise in translational research. Translational research is essential to make the link between basic research (basic mechanisms)
and clinical research (medical application).
To achieve our goals, we gathered the oncology strengths of 3 major AP-HP hospitals
(Georges Pompidou, Cochin and Necker).
CARPEM SIRIC brings together 350 doctors and researchers dedicated to care and research.
Metabolism, Genetics,
Immunity & Environment
The first challenge is to integrate metabolism in its broad sense, ranging from risk factors related to the lifestyle (physical inactivity, obesity, eating habits…) to molecular mechanisms induced in tumor cells or immune cells…
Cancer heterogeneity : a challenge for patient management
The second challenge consists in the comprehensive study of tumors heterogeneity which plays an important role in cancer treatment resistance and constitutes the next frontier for developing an effective precision medicine…
Dynamic consent
and health democracy
This program addresses technical, clinical and ethical challenges of integration and sharing of data generated on a large scale by the technical advances implemented in both research and healthcare. This essential step requires the adherence of patients and their families to become active players in cancer research…
The engineer will be attached to the “Center of Biological Resources, Cellulothèque and Tumorothèque” dependent on the services of Biochemistry, Biochemistry and Molecular Genetics, Biological
Wolf H Fridman, Catherine Sautès-Fridman and Anna Dimberg organize the “TLS in the era of cancer immunotherapy” symposium the day before the 5th cancer immunotherapy
This first edition, dedicated to digestive oncology, was organized by Pr Gérard Friedlander, Pr Pierre Laurent-Puig and Pr Jessica Zucman-Rossi, on November 15, 2018 at
A Suicide Gene Therapy Combining the Improvement of Cyclophosphamide Tumor Cytotoxicity and the Development of an Anti-Tumor Immune Response. Touati W, Tran T, Seguin
We federate 10 clinical teams from 3 major Parisian hospitals (HEGP, Cochin and Necker) that work on a large spectrum of cancers…
21 research teams working in the most famous Parisian institutes are dedicated to research against cancer…
CARPEM supports and sets up technological platforms that facilitate the collaborative work of our clinical and scientific teams…
2019 calls for projects are closed !
For more information, please contact
Centre Universitaire des Saints-Pères Etage 4 – Pièce 446B 45 rue des Saints-Pères -75006 Paris
Carina Binet : Secrétaire Général du CARPEM
Tél. : 01 76 53 43 85 – carina.binet@carpem.fr
Aurore Hattabi, PhD : Coordinatrice Scientifique du CARPEM
Tél : 01 76 53 43 85 – aurore.hattabi@carpem.fr
